About C3J Therapeutics
C3J Therapeutics is a company based in Los Angeles (United States) founded in 2006.. C3J Therapeutics has raised $214.5 million across 9 funding rounds from investors including HHS, Renaissance Acquisition Holdings and Delta Dental. The company has 60 employees as of December 31, 2021. C3J Therapeutics offers products and services including Bacteriophages, Synthetic Phage Platform, AP-PA02, and AP-PA03. C3J Therapeutics operates in a competitive market with competitors including Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
- Headquarter Los Angeles, United States
- Employees 60 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name C3j Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$214.5 M (USD)
in 9 rounds
-
Latest Funding Round
$19 M (USD), Series D
Dec 14, 2016
-
Investors
HHS
& 2 more
-
Employee Count
60
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C3J Therapeutics
C3J Therapeutics offers a comprehensive portfolio of products and services, including Bacteriophages, Synthetic Phage Platform, AP-PA02, and AP-PA03. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for targeting and destroying bacterial pathogens.
System for developing engineered phages against infections.
Therapeutic for specific bacterial infections and resistance.
Advanced phage therapy for combating resistant bacteria.
Funding Insights of C3J Therapeutics
C3J Therapeutics has successfully raised a total of $214.5M across 9 strategic funding rounds. The most recent funding activity was a Series D round of $19 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series D — $19.0M
-
First Round
First Round
(17 Aug 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Series D - C3J Therapeutics | Valuation |
investors |
|
| Dec, 2015 | Amount | Grant - C3J Therapeutics | Valuation |
investors |
|
| Mar, 2014 | Amount | Series D - C3J Therapeutics | Valuation | Renaissance Acquisition Holdings |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in C3J Therapeutics
C3J Therapeutics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, Renaissance Acquisition Holdings and Delta Dental. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Online gaming and gambling platform
|
Founded Year | Domain | Location | |
|
Dental insurance plans are offered by Delta Dental nationwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by C3J Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - C3J Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
C3j Therapeutics Comparisons
Competitors of C3J Therapeutics
C3J Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized MRI platforms for clinical diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on C3j Therapeutics
Frequently Asked Questions about C3J Therapeutics
When was C3J Therapeutics founded?
C3J Therapeutics was founded in 2006 and raised its 1st funding round 3 years after it was founded.
Where is C3J Therapeutics located?
C3J Therapeutics is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Is C3J Therapeutics a funded company?
C3J Therapeutics is a funded company, having raised a total of $214.5M across 9 funding rounds to date. The company's 1st funding round was a Series D of $60.5M, raised on Aug 17, 2009.
How many employees does C3J Therapeutics have?
As of Dec 31, 2021, the latest employee count at C3J Therapeutics is 60.
What does C3J Therapeutics do?
C3J Therapeutics was established in 2006 in Los Angeles, United States, with operations centered on the biotechnology sector. Specifically targeted antimicrobial peptides (STAMPs) are advanced for treating and preventing conditions linked to microbial dysbiosis. Key pipeline elements include C16G2, advanced to Phase 2 for dental caries prevention, and CD17-DL, in Phase 1 for C. difficile infection management. A PCR-based diagnostic for S. mutans detection is also in development.
Who are the top competitors of C3J Therapeutics?
C3J Therapeutics's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does C3J Therapeutics offer?
C3J Therapeutics offers Bacteriophages, Synthetic Phage Platform, AP-PA02, and AP-PA03.
Who are C3J Therapeutics's investors?
C3J Therapeutics has 3 investors. Key investors include HHS, Renaissance Acquisition Holdings, and Delta Dental.